Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.5K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

75
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
75
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

65
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
65
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

57
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
57
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

154
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
154

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of Distal Internal Carotid Artery Contrast Ratio to Infer Proximal Carotid Disease in the Mobile Stroke Unit.

Stroke (Hoboken, N.J.)Ā·2026
Same author

Advances in Acute Ischemic Stroke 2025: Medical Treatments.

StrokeĀ·2026
Same author

Chinese stroke association guidelines on construction of direct transfer to angiography suite.

Stroke and vascular neurologyĀ·2026
Same author

Effects of Fibrinogen on Tenecteplase Treatment in Acute Ischaemic Stroke After 4.5 Hours of Symptom Onset: A Post Hoc Analysis of the TRACE-III Trial.

Neurology and therapyĀ·2026
Same author

Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE): protocol for an international investigator-initiated, prospective, randomised, open, blinded endpoint assessment (PROBE) interventional multi-centre trial.

European stroke journalĀ·2026
Same author

Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication.

Lancet (London, England)Ā·2026

Related Experiment Video

Updated: Oct 23, 2025

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.0K

Tenecteplase Thrombolysis in Posterior Circulation Stroke.

Fana Alemseged1, Bruce C V Campbell1

  • 1Department of Medicine and Neurology, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.

Frontiers in Neurology
|August 23, 2021
PubMed
Summary

Tenecteplase shows promise for treating basilar artery occlusion, a severe stroke type. It offers higher reperfusion rates and practical benefits over alteplase, especially for transfer patients.

Keywords:
alteplasebasilar artery occlusionposterior circulation stroketenecteplasethrombolytic agent

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.2K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.1K

Related Experiment Videos

Last Updated: Oct 23, 2025

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.0K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.2K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.1K

Area of Science:

  • Neurology
  • Vascular Medicine
  • Pharmacology

Background:

  • Posterior circulation ischaemic stroke, including basilar artery occlusion, carries high mortality and disability risks.
  • Current treatments like alteplase have limited reperfusion success (~4%) in basilar artery occlusion.
  • Tenecteplase, a modified alteplase, offers improved fibrin specificity, a longer half-life, and bolus administration.

Purpose of the Study:

  • To evaluate tenecteplase as an alternative to alteplase for basilar artery occlusion.
  • To compare reperfusion rates and functional outcomes between tenecteplase and alteplase.
  • To assess the practical advantages of tenecteplase in 'drip and ship' scenarios.

Main Methods:

  • Observational data analysis comparing tenecteplase and alteplase in basilar artery occlusion patients.
  • Review of findings from the EXTEND-IA TNK trial for large-vessel occlusion strokes.
  • Comparison of reperfusion rates and modified Rankin Scale outcomes.

Main Results:

  • Tenecteplase achieved significantly higher reperfusion rates (26%) compared to alteplase (7%) in observational basilar artery occlusion data.
  • The EXTEND-IA TNK trial showed higher reperfusion (22% vs 10%) and improved functional outcomes with tenecteplase in large-vessel occlusion.
  • Tenecteplase's bolus administration is a key practical advantage, especially for inter-hospital transfers.

Conclusions:

  • Tenecteplase demonstrates potential as an effective alternative to alteplase for basilar artery occlusion.
  • Further randomized controlled trials are warranted to confirm these findings.
  • Tenecteplase offers significant advantages in reperfusion efficacy and administration practicality for basilar artery occlusion patients.